<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1688-0390</journal-id>
<journal-title><![CDATA[Revista Médica del Uruguay]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. Méd. Urug.]]></abbrev-journal-title>
<issn>1688-0390</issn>
<publisher>
<publisher-name><![CDATA[Sindicato Médico del Uruguay]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1688-03902025000201202</article-id>
<article-id pub-id-type="doi">10.29193/rmu.41.2.2</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Cáncer diferenciado de tiroides: resultados del seguimiento en endocrinología en Soriano, Young y Rivera (2001-2020)]]></article-title>
<article-title xml:lang="en"><![CDATA[Differentiated thyroid cancer: follow-up results in endocrinology in Soriano, Young, and Rivera (2001-2020)]]></article-title>
<article-title xml:lang="pt"><![CDATA[Câncer de tireoide diferenciado: resultados do acompanhamento em endocrinologia em Soriano, Young e Rivera (2001-2020)]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Orellano]]></surname>
<given-names><![CDATA[Pablo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Perna]]></surname>
<given-names><![CDATA[Abayuba]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Jacovenco]]></surname>
<given-names><![CDATA[Richard]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Vignolo]]></surname>
<given-names><![CDATA[Milena]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Lliviria]]></surname>
<given-names><![CDATA[Macarena]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[Jenifer]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Maglione]]></surname>
<given-names><![CDATA[Oscar]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Vicente]]></surname>
<given-names><![CDATA[Juan]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Méndez]]></surname>
<given-names><![CDATA[Guzmán]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Mercedes  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Uruguay</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Unidad de Evaluación del Fondo Nacional de Recursos  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Uruguay</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Hospital Rivera  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Uruguay</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Hospital de Young  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Uruguay</country>
</aff>
<aff id="Af5">
<institution><![CDATA[,Cooperativa Médica Rivera  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Uruguay</country>
</aff>
<aff id="Af6">
<institution><![CDATA[,Cooperativa de Asistencia Médica Soriano  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Uruguay</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2025</year>
</pub-date>
<volume>41</volume>
<numero>2</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_arttext&amp;pid=S1688-03902025000201202&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_abstract&amp;pid=S1688-03902025000201202&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_pdf&amp;pid=S1688-03902025000201202&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Introducción: la incidencia creciente del cáncer diferenciado de tiroides contrasta con su naturaleza indolente. Comprender su presentación clínica, evolución y respuesta al tratamiento proporciona información clave para optimizar la atención de los pacientes.  Objetivo: analizar las características clínicas, el tratamiento y los resultados de los pacientes con cáncer diferenciado de tiroides en tres localidades del interior de Uruguay.  Pacientes y métodos: se realizó un estudio de cohorte retrospectivo con pacientes diagnosticados entre 2001 y 2020 en prestadores de salud públicos y privados de los departamentos de Soriano, Río Negro (Young) y Rivera. Los pacientes fueron estratificados según el riesgo de recurrencia utilizando los criterios de la Asociación Americana de Tiroides.  Resultados: el 91 % de los pacientes fueron mujeres, con una edad media al diagnóstico de 45 años. Se observó un incremento en los diagnósticos durante el período estudiado, en los cuales predominó el carcinoma papilar con un tamaño medio de 18,6 mm. El 92 % de los casos correspondieron a estadio TNM I. Según la estratificación de riesgo, 82 pacientes fueron de bajo riesgo, 31 de riesgo intermedio y 13 de alto riesgo. Se realizó tiroidectomía total en 121 pacientes, lobectomía en 4 casos y solo un paciente fue manejado con seguimiento activo. El tratamiento con radioyodo se utilizó en 110 pacientes. Se registró recurrencia en 9 casos, asociada principalmente a multifocalidad y metástasis ganglionares laterales. Al final del seguimiento, el 72 % de los pacientes estaban libres de enfermedad y la supervivencia global fue del 98 %, con una mediana de seguimiento de 7 años.  Conclusión: las características clínicas de los pacientes con cáncer diferenciado de tiroides atendidos en policlínicas de endocrinología del interior de Uruguay son comparables a las de centros de alto volumen. Su pronóstico es excelente y el tratamiento ha evolucionado conforme a las nuevas recomendaciones según el riesgo de recurrencia.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Introduction: The increasing incidence of differentiated thyroid cancer contrasts with its indolent nature. Understanding its clinical presentation, evolution, and treatment response provides essential information to optimize patient care.  Objective: To analyze the clinical characteristics, treatment, and outcomes of patients with differentiated thyroid cancer in three regions of Uruguay.  Patients and methods: A retrospective cohort study was conducted on patients diagnosed between 2001 and 2020 in public and private healthcare providers in the departments of Soriano, Río Negro (Young), and Rivera. Patients were categorized according to recurrence risk using the American Thyroid Association criteria.  Results: Women accounted for 91 % of the patients, with a mean age at diagnosis of 45 years. Diagnoses increased over the study period, with papillary carcinoma being predominant and a mean tumor size of 18,6 mm. A total of 92 % of cases were classified as TNM stage I. Based on recurrence risk, 82 patients were low risk, 31 intermediate risk, and 13 high risk. Total thyroidectomy was performed in 121 patients, lobectomy in 4, and 1 patient underwent active surveillance. Radioiodine treatment was administered to 110 patients. Recurrence was observed in 9 cases, mainly associated with multifocality and lateral compartment lymph node metastases. At the end of follow-up, 72 % of patients were disease-free, and overall survival was 98 %, with a median follow-up of 7 years.  Conclusion: The clinical characteristics of patients with differentiated thyroid cancer treated in endocrinology clinics in Uruguay&#8217;s interior regions are comparable to those seen in high-volume centers. Prognosis is excellent, and treatment has evolved according to updated recommendations based on recurrence risk.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo  Introdução: A crescente incidência do câncer diferenciado de tireoide contrasta com sua natureza indolente. Compreender sua apresentação clínica, evolução e resposta ao tratamento fornece informações essenciais para otimizar o cuidado dos pacientes.  Objetivo: Analisar as características clínicas, o tratamento e os resultados dos pacientes com câncer diferenciado de tireoide em três localidades do interior do Uruguai.  Pacientes e métodos: Foi realizado um estudo de coorte retrospectivo com pacientes diagnosticados entre 2001 e 2020 em prestadores de saúde públicos e privados nos departamentos de Soriano, Rio Negro (Young) e Rivera. Os pacientes foram estratificados de acordo com o risco de recorrência, utilizando os critérios da Associação Americana de Tireoide.  Resultados: 91 % dos pacientes eram mulheres, com idade média ao diagnóstico de 45 anos. Observou-se um aumento nos diagnósticos durante o período estudado, com predominância do carcinoma papilífero e um tamanho médio de tumor de 18,6 mm. No total, 92 % dos casos foram classificados como TNM estágio I. Com base no risco de recorrência, 82 pacientes foram de baixo risco, 31 de risco intermediário e 13 de alto risco. A tireoidectomia total foi realizada em 121 pacientes, lobectomia em 4, e 1 paciente foi acompanhado por vigilância ativa. O tratamento com radioiodo foi utilizado em 110 pacientes. A recorrência foi observada em 9 casos, principalmente associada à multifocalidade e metástases linfonodais do compartimento lateral. No final do acompanhamento, 72 % dos pacientes estavam livres da doença e a sobrevida global foi de 98 %, com mediana de seguimento de 7 anos.  Conclusão: As características clínicas dos pacientes com câncer diferenciado de tireoide atendidos em clínicas de endocrinologia no interior do Uruguai são comparáveis às de centros de alto volume. O prognóstico é excelente e o tratamento evoluiu de acordo com as novas recomendações baseadas no risco de recorrência.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Cáncer diferenciado de tiroides]]></kwd>
<kwd lng="es"><![CDATA[Riesgo de recurrencia]]></kwd>
<kwd lng="es"><![CDATA[Estratificación de riesgo]]></kwd>
<kwd lng="es"><![CDATA[Tasa de supervivencia]]></kwd>
<kwd lng="es"><![CDATA[Seguimiento en endocrinología]]></kwd>
<kwd lng="en"><![CDATA[Differentiated thyroid cancer]]></kwd>
<kwd lng="en"><![CDATA[Recurrence risk]]></kwd>
<kwd lng="en"><![CDATA[Risk stratification]]></kwd>
<kwd lng="en"><![CDATA[Survival rate]]></kwd>
<kwd lng="en"><![CDATA[Endocrinology follow-up]]></kwd>
<kwd lng="pt"><![CDATA[Câncer diferenciado de tireoide]]></kwd>
<kwd lng="pt"><![CDATA[Risco de recorrência]]></kwd>
<kwd lng="pt"><![CDATA[Estratificação de risco]]></kwd>
<kwd lng="pt"><![CDATA[Taxa de sobrevida]]></kwd>
<kwd lng="pt"><![CDATA[Acompanhamento em endocrinologia]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[AY]]></given-names>
</name>
<name>
<surname><![CDATA[Jemal]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ward]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005]]></article-title>
<source><![CDATA[Cancer [Internet]]]></source>
<year>2009</year>
<volume>115</volume>
<numero>16</numero>
<issue>16</issue>
<page-range>3801-7</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pitoia]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Califano]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Vázquez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Faure]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Gauna]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Orlandi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Consenso intersocietario sobre tratamiento y seguimiento de pacientes con cáncer diferenciado de tiroides]]></article-title>
<source><![CDATA[Rev Argent Endocrinol Metab]]></source>
<year>2014</year>
<volume>51</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>85-118</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3.</label><nlm-citation citation-type="">
<collab>National Cancer Institute Surveillance, Epidemiology, and End Results Program</collab>
<source><![CDATA[Cancer Stat Facts: Thyroid Cancer]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B4">
<label>4.</label><nlm-citation citation-type="">
<collab>Comisión Honoraria de Lucha contra el Cáncer</collab>
<source><![CDATA[Situación epidemiológica del Uruguay en relación al cáncer 2023 [Internet]]]></source>
<year></year>
<publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B5">
<label>5.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cooper]]></surname>
<given-names><![CDATA[DS]]></given-names>
</name>
<name>
<surname><![CDATA[Doherty]]></surname>
<given-names><![CDATA[GM]]></given-names>
</name>
<name>
<surname><![CDATA[Haugen]]></surname>
<given-names><![CDATA[BR]]></given-names>
</name>
<name>
<surname><![CDATA[Kloos]]></surname>
<given-names><![CDATA[RT]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[SL]]></given-names>
</name>
<name>
<surname><![CDATA[Mandel]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer: The American thyroid association (ATA) guidelines taskforce on thyroid nodules and differentiated thyroid cancer]]></article-title>
<source><![CDATA[Thyroid]]></source>
<year>2009</year>
<volume>19</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1167-214</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Haugen]]></surname>
<given-names><![CDATA[BR]]></given-names>
</name>
<name>
<surname><![CDATA[Alexander]]></surname>
<given-names><![CDATA[EK]]></given-names>
</name>
<name>
<surname><![CDATA[Bible]]></surname>
<given-names><![CDATA[KC]]></given-names>
</name>
<name>
<surname><![CDATA[Doherty]]></surname>
<given-names><![CDATA[GM]]></given-names>
</name>
<name>
<surname><![CDATA[Mandel]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
<name>
<surname><![CDATA[Nikiforov]]></surname>
<given-names><![CDATA[YE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer]]></article-title>
<source><![CDATA[Thyroid]]></source>
<year>2016</year>
<volume>26</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-133</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pacini]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Fuhrer]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Elisei]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Handkiewicz-Junak]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Leboulleux]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Luster]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?]]></article-title>
<source><![CDATA[Eur Thyroid J]]></source>
<year>2022</year>
<volume>11</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>G1-9</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pitoia]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Ward]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Wohllk]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Friguglietti]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Tomimori]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Gauna]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Recommendations of the Latin American Thyroid Society on diagnosis and management of differentiated thyroid cancer]]></article-title>
<source><![CDATA[Arq Bras Endocrinol Metabol]]></source>
<year>2009</year>
<volume>53</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>884-7</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9.</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Belzarena]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Lago]]></surname>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Irrazábal]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Crestanello]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Caputi]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<source><![CDATA[Primer Consenso Uruguayo sobre tratamiento y seguimiento del cáncer diferenciado de tiroides]]></source>
<year>2000</year>
<page-range>16</page-range><publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
<publisher-name><![CDATA[Lab Dispert]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<label>10.</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cimarra]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cáncer de tiroides en general. Carcinomas diferenciados: carcinoma papilar y carcinoma folicular]]></article-title>
<source><![CDATA[Diagnóstico y tratamiento de las enfermedades quirúrgicas de la glándula tiroides]]></source>
<year>2006</year>
<edition>1a ed</edition>
<page-range>97-150</page-range><publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
<publisher-name><![CDATA[Oficina del Libro &#8211; FEFMUR]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<label>11.</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alonso]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Seguimiento cáncer diferenciado de tiroides (CDT)]]></article-title>
<source><![CDATA[Abordaje de la patología nodular tiroidea. Facultad de Medicina]]></source>
<year>2013</year>
<page-range>61-9</page-range><publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
<publisher-name><![CDATA[Comisión Sectorial de Educación Permanente, Facultad de Medicina]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B12">
<label>12.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mintegui]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Casamayou]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Arciénega]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Mendoza]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Ronco]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Caracterización de pacientes con microcarcinoma papilar de tiroides en el Hospital de Clínicas (UDELAR) en los últimos 10 años]]></article-title>
<source><![CDATA[Rev Méd Urug]]></source>
<year>2021</year>
<volume>37</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>e204</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13.</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Orellano]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Cortez]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<source><![CDATA[Microcarcinoma papilar de tiroides: caracterización clínica patológica período 1977-2005]]></source>
<year>2005</year>
<publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
<publisher-name><![CDATA[Facultad de Medicina, Hospital de Clínicas]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B14">
<label>14.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Parada]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Elicegui]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Guarneri]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Mintegui]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Neirotti]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Microcarcinoma papilar de tiroides: Vigilancia activa. Revisión de la bibliografía]]></article-title>
<source><![CDATA[Endocrinología y Diabetes]]></source>
<year>2023</year>
<volume>16</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>124-9</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15.</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Armand Ugon]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<source><![CDATA[Cáncer de tiroides. Clínicas Quirúrgicas, Facultad de Medicina, Universidad de la República]]></source>
<year>2019</year>
<publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
<publisher-name><![CDATA[Universidad de la República]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B16">
<label>16.</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Savio]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Reyes]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Camejo]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<source><![CDATA[Pautas de oncología médica: cáncer de tiroides, octubre-noviembre]]></source>
<year>2022</year>
<publisher-loc><![CDATA[Montevideo: UDELAR ]]></publisher-loc>
<publisher-name><![CDATA[Cátedra de Oncología Clínica, Universidad de la República]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B17">
<label>17.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pritsch]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Finozzi]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Neira]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Rol de la dosificación de tiroglobulina en el líquido de lavado de la punción por aguja fina para el diagnóstico de metástasis ganglionares en el seguimiento de cáncer de tiroides en el Hospital de Clínicas de Montevideo, Uruguay]]></article-title>
<source><![CDATA[Rev Méd Urug]]></source>
<year>2022</year>
<volume>38</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>e38302</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tuttle]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Tala]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Shah]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Leboeuf]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Ghossein]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Gonen]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system]]></article-title>
<source><![CDATA[Thyroid]]></source>
<year>2010</year>
<volume>20</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1341-9</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Momesso]]></surname>
<given-names><![CDATA[DP]]></given-names>
</name>
<name>
<surname><![CDATA[Vaisman]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[SP]]></given-names>
</name>
<name>
<surname><![CDATA[Bulzico]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
<name>
<surname><![CDATA[Corbo]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Vaisman]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dynamic risk stratification in patients with differentiated thyroid cancer treated without radioactive iodine]]></article-title>
<source><![CDATA[J Clin Endocrinol Metab]]></source>
<year>2016</year>
<volume>101</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>2692-700</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Xu]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Ghossein]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): An update]]></article-title>
<source><![CDATA[Head Neck Pathol]]></source>
<year>2020</year>
<volume>14</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>303-10</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Amin]]></surname>
<given-names><![CDATA[MB]]></given-names>
</name>
<name>
<surname><![CDATA[Greene]]></surname>
<given-names><![CDATA[FL]]></given-names>
</name>
<name>
<surname><![CDATA[Edge]]></surname>
<given-names><![CDATA[SB]]></given-names>
</name>
<name>
<surname><![CDATA[Compton]]></surname>
<given-names><![CDATA[CC]]></given-names>
</name>
<name>
<surname><![CDATA[Gershenwald]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Brookland]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more «personalized» approach to cancer staging]]></article-title>
<source><![CDATA[CA: Cancer J Clin]]></source>
<year>2017</year>
<volume>67</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>93-9</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cibas]]></surname>
<given-names><![CDATA[ES]]></given-names>
</name>
<name>
<surname><![CDATA[Ali]]></surname>
<given-names><![CDATA[SZ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The 2017 Bethesda system for reporting thyroid cytopathology]]></article-title>
<source><![CDATA[Thyroid]]></source>
<year>2017</year>
<volume>27</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1341-6</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23.</label><nlm-citation citation-type="">
<collab>Comisión Honoraria de Lucha contra el Cáncer</collab>
<source><![CDATA[Estadísticas por Departamentos]]></source>
<year></year>
<publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B24">
<label>24.</label><nlm-citation citation-type="">
<collab>Instituto Nacional de Estadística</collab>
<source><![CDATA[Censos]]></source>
<year>2011</year>
</nlm-citation>
</ref>
<ref id="B25">
<label>25.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Udelsman]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The epidemic of thyroid cancer in the United States: the Role of endocrinologists and ultrasounds]]></article-title>
<source><![CDATA[Thyroid]]></source>
<year>2014</year>
<volume>24</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>472-9</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jung]]></surname>
<given-names><![CDATA[CK]]></given-names>
</name>
<name>
<surname><![CDATA[Little]]></surname>
<given-names><![CDATA[MP]]></given-names>
</name>
<name>
<surname><![CDATA[Lubin]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
<name>
<surname><![CDATA[Brenner]]></surname>
<given-names><![CDATA[AV]]></given-names>
</name>
<name>
<surname><![CDATA[Wells Jr]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Sigurdson]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The increase in thyroid cancer incidence during the last four decades is accompanied by a high frequency of BRAF mutations and a sharp increase in RAS mutations]]></article-title>
<source><![CDATA[J Clin Endocrinol Metab]]></source>
<year>2014</year>
<volume>99</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>E276-85</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Adam]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Pura]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Gu]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Dinan]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Tyler]]></surname>
<given-names><![CDATA[DS]]></given-names>
</name>
<name>
<surname><![CDATA[Reed]]></surname>
<given-names><![CDATA[SD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Extent of surgery for papillary thyroid cancer is not associated with survival: An analysis of 61,775 patients]]></article-title>
<source><![CDATA[Ann Surg]]></source>
<year>2014</year>
<volume>260</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>601-7</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Patel]]></surname>
<given-names><![CDATA[KN]]></given-names>
</name>
<name>
<surname><![CDATA[Yip]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Lubitz]]></surname>
<given-names><![CDATA[CC]]></given-names>
</name>
<name>
<surname><![CDATA[Grubbs]]></surname>
<given-names><![CDATA[EG]]></given-names>
</name>
<name>
<surname><![CDATA[Miller]]></surname>
<given-names><![CDATA[BS]]></given-names>
</name>
<name>
<surname><![CDATA[Shen]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The American Association of Endocrine Surgeons guidelines for the definitive surgical management of thyroid disease in adults]]></article-title>
<source><![CDATA[Ann Surg]]></source>
<year>2020</year>
<volume>271</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>e21-93</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Miyauchi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Kudo]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Ito]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Oda]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Sasai]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Higashiyama]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estimation of the lifetime probability of disease progression of papillary microcarcinoma of the thyroid during active surveillance]]></article-title>
<source><![CDATA[Surgery]]></source>
<year>2018</year>
<volume>163</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>48-52</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Worrall]]></surname>
<given-names><![CDATA[BJ]]></given-names>
</name>
<name>
<surname><![CDATA[Papachristos]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Aniss]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Glover]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sidhu]]></surname>
<given-names><![CDATA[SB]]></given-names>
</name>
<name>
<surname><![CDATA[Clifton-Bligh]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Lobectomy and completion thyroidectomy rates increase after the 2015 American Thyroid Association Differentiated Thyroid Cancer Guidelines update]]></article-title>
<source><![CDATA[Endocr Oncol]]></source>
<year>2023</year>
<volume>3</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>e220095</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Huang]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Xu]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Ni]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Long-term outcome of thyroid lobectomy for unilateral multifocal papillary carcinoma]]></article-title>
<source><![CDATA[Medicine (Baltimore)]]></source>
<year>2017</year>
<volume>96</volume>
<numero>27</numero>
<issue>27</issue>
<page-range>e7461</page-range></nlm-citation>
</ref>
<ref id="B32">
<label>32.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pacini]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Basolo]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Bellantone]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Boni]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Cannizzaro]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[De Palma]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies]]></article-title>
<source><![CDATA[J Endocrinol Invest]]></source>
<year>2018</year>
<volume>41</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>849-76</page-range></nlm-citation>
</ref>
<ref id="B33">
<label>33.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kluijfhout]]></surname>
<given-names><![CDATA[WP]]></given-names>
</name>
<name>
<surname><![CDATA[Pasternak]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
<name>
<surname><![CDATA[Lim]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Kwon]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
<name>
<surname><![CDATA[Vriens]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Clark]]></surname>
<given-names><![CDATA[OH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Frequency of high-risk characteristics requiring total thyroidectomy for 1-4cm well-differentiated thyroid cancer]]></article-title>
<source><![CDATA[Thyroid]]></source>
<year>2016</year>
<volume>26</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>820-4</page-range></nlm-citation>
</ref>
<ref id="B34">
<label>34.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hauch]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Al-Qurayshi]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Randolph]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Kandil]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Total thyroidectomy is associated with increased risk of complications for low- and highvolume surgeons]]></article-title>
<source><![CDATA[Ann Surg Oncol]]></source>
<year>2014</year>
<volume>21</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>3844-52</page-range></nlm-citation>
</ref>
<ref id="B35">
<label>35.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Canu]]></surname>
<given-names><![CDATA[GL]]></given-names>
</name>
<name>
<surname><![CDATA[Medas]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Cappellacci]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Giordano]]></surname>
<given-names><![CDATA[ABF]]></given-names>
</name>
<name>
<surname><![CDATA[Gurrado]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Gambardella]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Risk of complications in patients undergoing completion thyroidectomy after hemithyroidectomy for thyroid nodule with indeterminate cytology: An Italian multicentre retrospective study]]></article-title>
<source><![CDATA[Cancers (Basel)]]></source>
<year>2022</year>
<volume>14</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>2472</page-range></nlm-citation>
</ref>
<ref id="B36">
<label>36.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chou]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Dana]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Haymart]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Leung]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Tufano]]></surname>
<given-names><![CDATA[RP]]></given-names>
</name>
<name>
<surname><![CDATA[Sosa]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Active surveillance versus thyroid surgery for differentiated thyroid cancer: A systematic review]]></article-title>
<source><![CDATA[Thyroid]]></source>
<year>2022</year>
<volume>32</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>351-67</page-range></nlm-citation>
</ref>
<ref id="B37">
<label>37.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hong]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[Ahn]]></surname>
<given-names><![CDATA[B-C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factors associated with dose determination of radioactive iodine therapy for differentiated thyroid cancer]]></article-title>
<source><![CDATA[Nucl Med Mol Imaging]]></source>
<year>2018</year>
<volume>52</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>247-53</page-range></nlm-citation>
</ref>
<ref id="B38">
<label>38.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schlumberger]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Leboulleux]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Catargi]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Deandreis]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Zerdoud]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Bardet]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial]]></article-title>
<source><![CDATA[Lancet Diabetes Endocrinol]]></source>
<year>2018</year>
<volume>6</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>618-26</page-range></nlm-citation>
</ref>
<ref id="B39">
<label>39.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tuttle]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Ahuja]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Avram]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Bernet]]></surname>
<given-names><![CDATA[VJ]]></given-names>
</name>
<name>
<surname><![CDATA[Bourguet]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Daniels]]></surname>
<given-names><![CDATA[GH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Controversies, Consensus, and Collaboration in the Use of (131) I Therapy in Differentiated Thyroid Cancer: A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, and the European Thyroid Association]]></article-title>
<source><![CDATA[Thyroid]]></source>
<year>2019</year>
<volume>29</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>461-70</page-range></nlm-citation>
</ref>
<ref id="B40">
<label>40.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mazzaferri]]></surname>
<given-names><![CDATA[EL]]></given-names>
</name>
<name>
<surname><![CDATA[Young]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients]]></article-title>
<source><![CDATA[Am J Med]]></source>
<year>1981</year>
<volume>70</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>511-8</page-range></nlm-citation>
</ref>
<ref id="B41">
<label>41.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mercante]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Frasoldati]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Pedroni]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Formisano]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Renna]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Piana]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prognostic factors affecting neck lymph node recurrence and distant metástasis in papillary microcarcinoma of the thyroid: Results of a study in 445 patients]]></article-title>
<source><![CDATA[Thyroid]]></source>
<year>2009</year>
<volume>19</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>707-16</page-range></nlm-citation>
</ref>
<ref id="B42">
<label>42.</label><nlm-citation citation-type="book">
<collab>American Cancer Society</collab>
<source><![CDATA[Cancer facts and figures 2012]]></source>
<year>2012</year>
<publisher-loc><![CDATA[Atlanta (GA) ]]></publisher-loc>
<publisher-name><![CDATA[American Cancer Society]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B43">
<label>43.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lin]]></surname>
<given-names><![CDATA[J-D]]></given-names>
</name>
<name>
<surname><![CDATA[Hsueh]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Chao]]></surname>
<given-names><![CDATA[T-C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Long-term follow-up of the therapeutic outcomes for papillary thyroid carcinoma with distant metastasis]]></article-title>
<source><![CDATA[Medicine (Baltimore)]]></source>
<year>2015</year>
<volume>94</volume>
<numero>26</numero>
<issue>26</issue>
<page-range>e1063</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
